Einar Gudlaugsson

Einar Gudlaugsson

Auto-generated profile, based on publicly available information

Einar Gudlaugsson

Department of Pathology, Stavanger University Hospital, Helse Stavanger HF, P.O. Box 8100, N-4068, Stavanger, Norway

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

4 December 2019 in BMC Cancer
Verified
Journal Article
Open access
PDF file
TLTone Hoel Lende
Tone Hoel Lende
MAMarie Austdal
Marie Austdal
TBTone Frost Bathen
Tone Frost Bathen
AVAnne Elin Varhaugvik
Anne Elin Varhaugvik
ISIvar Skaland
Ivar Skaland
JBJan P. A. Baak
Jan P. A. Baak
Background: The metabolic consequences of preoperative carbohydrate load in breast cancer patients are not known. The present explorative study investigated the systemic and tumor metabolic changes after preoperative per-oral carbohydrate load and their influence on tumor characteristics and survival. Methods: The study setting was on university hospital level with primary and secondary care functions in south-west Norway. Serum and tumor tissue were sampled from a population-based cohort of 60 patients with operable breast cancer who were randomized to either per-oral carbohydrate load (preOp™; n = 25) or standard pre-operative fasting (n = 35) before surgery. Magnetic resonance (MR) metabolomics was performed on serum samples from all patients and high-resolution magic angle spinning (HR-MAS) MR analysis on 13 tumor samples available from the fasting group and 16 tumor samples from the carbohydrate group. Results: Fourteen of 28 metabolites were differently expressed between fasting and carbohydrate groups. Partial least squares discriminant analysis showed a significant difference in the metabolic profile between the fasting and carbohydrate groups, compatible with the endocrine effects of insulin (i.e., increased serum-lactate and pyruvate and decreased ketone bodies and amino acids in the carbohydrate group). Among ER-positive tumors (n = 18), glutathione was significantly elevated in the carbohydrate group compared to the fasting group (p = 0.002), with a positive correlation between preoperative S-insulin levels and the glutathione content in tumors (r = 0.680; p = 0.002). In all tumors (n = 29), glutamate was increased in tumors with high proliferation (t-test; p = 0.009), independent of intervention group. Moreover, there was a positive correlation between tumor size and proliferation markers in the carbohydrate group only. Patients with ER-positive / T2 tumors and high tumor glutathione (≥1.09), high S-lactate (≥56.9), and high S-pyruvate (≥12.5) had inferior clinical outcomes regarding relapse-free survival, breast cancer-specific survival, and overall survival. Moreover, Integrated Pathway Analysis (IPA) in serum revealed activation of five major anabolic metabolic networks contributing to proliferation and growth. Conclusions: Preoperative carbohydrate load increases systemic levels of lactate and pyruvate and tumor levels of glutathione and glutamate in ER-positive patients. These biological changes may contribute to the inferior clinical outcomes observed in luminal T2 breast cancer patients. Trial of registration: ClinicalTrials.gov; NCT03886389. Retrospectively registered March 22, 2019.

1 February 2011
Verified
Journal Article
Closed access
HZHui Zhang
Hui Zhang
ASAida Slewa
Aida Slewa
EJEmiel Janssen
Emiel Janssen
ISIvar Skaland
Ivar Skaland
YYYinhua Yu
Yinhua Yu
JBJan P. A. Baak
Jan P. A. Baak

28 June 2011 in Proteome Science
Verified
Journal Article
Open access
PDF file
KUKai-Erik Uleberg
Kai-Erik Uleberg
AMAne Cecilie Munk
Ane Cecilie Munk
CBCato Brede
Cato Brede
EGEinar Gudlaugsson
Einar Gudlaugsson
BDBianca van Diermen
Bianca van Diermen
JBJan Pa Baak
Jan Pa Baak
Background: Cervical intraepithelial neoplasia (CIN) grades 2 and 3 are usually grouped and treated in the same way as "high grade", in spite of their different risk to cancer progression and spontaneous regression rates. CIN2-3 is usually diagnosed in formaldehyde-fixed paraffin embedded (FFPE) punch biopsies. This procedure virtually eliminates the availability of water-soluble proteins which could have diagnostic and prognostic value. Aim: To investigate whether a water-soluble protein-saving biopsy processing method followed by a proteomic analysis of supernatant samples using LC-MS/MS (LTQ Orbitrap) can be used to distinguish between CIN2 and CIN3. Methods: Fresh cervical punch biopsies from 20 women were incubated in RPMI1640 medium for 24 hours at 4°C for protein extraction and subsequently subjected to standard FFPE processing. P16 and Ki67-supported histologic consensus review CIN grade (CIN2, n = 10, CIN3, n = 10) was assessed by independent gynecological pathologists. The biopsy supernatants were depleted of 7 high abundance proteins prior to uni-dimensional LC-MS/MS analysis for protein identifications. Results: The age of the patients ranged from 25-40 years (median 29.7), and mean protein concentration was 0.81 mg/ml (range 0.55 - 1.14). After application of multistep identification criteria, 114 proteins were identified, including proteins like vimentin, actin, transthyretin, apolipoprotein A-1, Heat Shock protein beta 1, vitamin D binding protein and different cytokeratins. The identified proteins are annotated to metabolic processes (36%), signal transduction (27%), cell cycle processes (15%) and trafficking/transport (9%). Using binary logistic regression, Cytokeratin 2 was found to have the strongest independent discriminatory power resulting in 90% overall correct classification. Conclusions: 114 proteins were identified in supernatants from fresh cervical biopsies and many differed between CIN2 and 3. Cytokeratin 2 is the strongest discriminator with 90% overall correct classifications.

26 March 2013 in Histopathology
Verified
Journal Article
Closed access
PDF file
WFWeiwei Feng
Weiwei Feng
AMAnais Malpica
Anais Malpica
YYYu Yinhua
Yu Yinhua
EJEmiel Janssen
Emiel Janssen
EGEinar Gudlaugsson
Einar Gudlaugsson
JBJan P. A. Baak
Jan P. A. Baak

1 June 2004
Verified
Journal Article
Closed access
AKAmold-Jan Kruse
Amold-Jan Kruse
EGEinar Gudlaugsson
Einar Gudlaugsson
THTove Helliesen
Tove Helliesen
EJEmiel A Janssen
Emiel A Janssen
BDBianca Van Diermen
Bianca Van Diermen
JBJan P Baak
Jan P Baak